Why would Novartis need to buy out MSB? They've just executed an excellent partnership with them that entitiles them to 50% of profits. Novartis got a great deal at excellent rates. We just got a massive floor underneath the stock price. I am amazed by todays stock price action.
Novartis see the value in non-COVID ARDS long-term. Seems the mkt is a little too hung up on the present FDA shnnigans which will not persist.
Is there any chance that Novartis will buy out Mesoblast?, page-13
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |